このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Madrigal Pharmaceuticals マネジメント
マネジメント 基準チェック /14
現在、CEO に関する十分な情報がありません。
主要情報
Bill Sibold
最高経営責任者
US$32.9m
報酬総額
| CEO給与比率 | 0.8% |
| CEO在任期間 | less than a year |
| CEOの所有権 | 0.03% |
| 経営陣の平均在職期間 | less than a year |
| 取締役会の平均在任期間 | 8.1yrs |
経営陣の近況
Recent updates
Broker Revenue Forecasts For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Are Surging Higher
Aug 09
While Madrigal's Rezdiffra Impresses, Great Uncertainties Loom In MASH Market
Aug 08Madrigal May Not Be Able To Shrug GLP-1 Drugs For Long
Jun 09Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage
Apr 24Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge
Mar 15Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potential
Feb 07Calculating The Intrinsic Value Of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Dec 20We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Aug 05Madrigal: Buy And Hoard Before Q4 Data Readout
Aug 04Madrigal cut to Neutral at B. Riley on concerns over upcoming NASH readout
Jul 08Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 11Madrigal: NASH Data In Q4 Is The Key
Apr 19We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Feb 24Madrigal: Delayed NASH Data Is Positive But Real Tests Are Still To Come
Jan 31Madrigal: Powerful Catalyst Approaching
Jan 09We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Nov 08We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Jul 26Madrigal Pharmaceuticals: Leading The NASH Innovation
May 05Here's Why We're Watching Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Situation
Apr 12We Think Madrigal Pharmaceuticals (NASDAQ:MDGL) Can Afford To Drive Business Growth
Dec 28
Madrigal Pharma: A Look At The Early MAESTRO Trial Data
Nov 27Madrigal Pharmaceuticals (MDGL) Presents At AASLD 2020 Conference- Slideshow
Nov 17CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$510m |
| Mar 31 2024 | n/a | n/a | -US$444m |
| Dec 31 2023 | US$33m | US$275k | -US$374m |
報酬と市場: Billの 総報酬 ($USD 32.87M ) は、 US市場 ($USD 8.45M ) の同規模の企業の平均を上回っています。
報酬と収益: Billの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Bill Sibold (58 yo)
less than a year
在職期間
US$32,871,801
報酬
Mr. William J. Sibold, also known as Bill, serves as Chief Executive Officer, President and Director at Madrigal Pharmaceuticals, Inc. since September 8, 2023. Mr. Sibold joined Madrigal Pharmaceuticals, I...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$32.87m | 0.028% $ 1.3m | |
| Founder | 13yrs | US$6.93m | 5.02% $ 233.1m | |
| Chief Commercial Officer | less than a year | US$3.14m | データなし | |
| CFO & Senior VP | less than a year | データなし | データなし | |
| Chief Information Officer | less than a year | データなし | データなし | |
| Chief Investor Relations Officer | less than a year | データなし | データなし | |
| Chief Compliance Office & General Counsel | less than a year | データなし | データなし | |
| Chief Human Resources Officer | less than a year | データなし | データなし | |
| Senior Vice President of Clinical & Technical Operations | no data | データなし | データなし | |
| Senior Vice President of Clinical Management | no data | データなし | データなし | |
| Chief Pharmaceutical Development Officer | 3.1yrs | データなし | 0.025% $ 1.2m | |
| Senior Vice President of Global Medical Affairs | 2.8yrs | データなし | データなし |
0.8yrs
平均在職期間
60yo
平均年齢
経験豊富な経営陣: MDGLの経営陣は 経験豊富 とはみなされません ( 0.6年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$32.87m | 0.028% $ 1.3m | |
| Founder | 8.2yrs | US$6.93m | 5.02% $ 233.1m | |
| Independent Lead Director | 8.2yrs | US$65.00k | 1.71% $ 79.3m | |
| Independent Director | 8.2yrs | US$77.50k | 0.0055% $ 256.4k | |
| Independent Chairman of the Board | 1.3yrs | US$33.75k | 0.011% $ 512.7k | |
| Director | 8.2yrs | US$9.80m | 4.37% $ 202.9m | |
| Independent Director | 8.1yrs | US$62.50k | 0.047% $ 2.2m | |
| Independent Director | 5.3yrs | US$57.50k | 0.0055% $ 256.4k | |
| Independent Director | 1.3yrs | US$27.50k | 0.011% $ 512.7k |
8.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: MDGLの 取締役会 は 経験豊富 であると考えられます ( 7.8年の平均在任期間)。